The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm
General structure of peptides, peptoids, peptomers and backbone cyclic peptomers. A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe- d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) whi...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2010-01, Vol.18 (2), p.580-589 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 589 |
---|---|
container_issue | 2 |
container_start_page | 580 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 18 |
creator | Ovadia, Oded Linde, Yaniv Haskell-Luevano, Carrie Dirain, Marvin L. Sheynis, Tanya Jelinek, Raz Gilon, Chaim Hoffman, Amnon |
description | General structure of peptides, peptoids, peptomers and backbone cyclic peptomers.
A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe-
d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) which participates in regulation of energy homeostasis and appetite. The library of peptomers included a peptoid bond in the Phe and/or
d-Phe position and consisted of linear and backbone cyclic analogs, differed in their ring size. While the linear peptides rapidly degraded in serum and in brush border membrane vesicles (BBMV’s), the linear peptomers were more stable. Backbone cyclic peptomers were also stable under the same conditions. Backbone cyclization significantly increased the intestinal permeability of two peptomers compared to their linear counterparts, in the Caco-2 model. Pharmacological evaluation revealed that two linear and one backbone cyclic peptomer, were found active towards MC4R at the nanomolar range. Thus, the conformational constrains imposed by these local and global modifications affect both the pharmacokinetic and pharmacodynamic properties of the parent peptide. This study demonstrates the potential of imposing backbone cyclization on bioactive peptomers as a promising approach in developing an orally available peptidomimetic drug leads. |
doi_str_mv | 10.1016/j.bmc.2009.12.010 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733910406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089609010943</els_id><sourcerecordid>733910406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-cacd856bd2e4a4fec7c84ba6401e385920a6ac1eeaf60904da74a80c68dbfba93</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi0EotvCA3BBviBOSe3E643hVBUKiEr0UM7WZDxpvSRxsLOVlgPPjsMucEOyNJfv_zX-hrEXUpRSSH2-LdsBy0oIU8qqFFI8YiuptCrq2sjHbCWMbgrRGH3CTlPaCiEqZeRTdpIja71WasV-3t4Tp64jnHnoeAv4rQ0jcdxj73_A7MPI87v5fH7zjk8xTBRnT-k36wPg7B-ITzTN3lGxzOAdv9-30bv0hi_lA_UwBgw5N3K4C6NPM58ggvN3wzP2pIM-0fPjPGNfr97fXn4srr98-HR5cV2gUs1cIKBr1rp1FSlQedkNNqoFrYSkulmbSoAGlETQaWGEcrBR0AjUjWu7Fkx9xl4fevMXvu8ozXbwCanPq1HYJbtZjAkldCblgcQYUorU2Sn6AeLeSmEX63Zrs3W7WLeystl6zrw8tu_agdzfxB_NGXh1BCAh9F2EEX36x1W13kizFL09cJRdPHiKNqGnEcn5mC9kXfD_WeMXYhmh-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733910406</pqid></control><display><type>article</type><title>The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Ovadia, Oded ; Linde, Yaniv ; Haskell-Luevano, Carrie ; Dirain, Marvin L. ; Sheynis, Tanya ; Jelinek, Raz ; Gilon, Chaim ; Hoffman, Amnon</creator><creatorcontrib>Ovadia, Oded ; Linde, Yaniv ; Haskell-Luevano, Carrie ; Dirain, Marvin L. ; Sheynis, Tanya ; Jelinek, Raz ; Gilon, Chaim ; Hoffman, Amnon</creatorcontrib><description>General structure of peptides, peptoids, peptomers and backbone cyclic peptomers.
A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe-
d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) which participates in regulation of energy homeostasis and appetite. The library of peptomers included a peptoid bond in the Phe and/or
d-Phe position and consisted of linear and backbone cyclic analogs, differed in their ring size. While the linear peptides rapidly degraded in serum and in brush border membrane vesicles (BBMV’s), the linear peptomers were more stable. Backbone cyclic peptomers were also stable under the same conditions. Backbone cyclization significantly increased the intestinal permeability of two peptomers compared to their linear counterparts, in the Caco-2 model. Pharmacological evaluation revealed that two linear and one backbone cyclic peptomer, were found active towards MC4R at the nanomolar range. Thus, the conformational constrains imposed by these local and global modifications affect both the pharmacokinetic and pharmacodynamic properties of the parent peptide. This study demonstrates the potential of imposing backbone cyclization on bioactive peptomers as a promising approach in developing an orally available peptidomimetic drug leads.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2009.12.010</identifier><identifier>PMID: 20056544</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Backbone cyclization ; Biological and medical sciences ; Biological Transport - drug effects ; Caco-2 Cells ; Cell Line ; Cell Membrane Permeability - drug effects ; Cyclization ; Humans ; Medical sciences ; Melanocortin ; Molecular Conformation ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptide Library ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Peptides, Cyclic - chemical synthesis ; Peptides, Cyclic - chemistry ; Peptides, Cyclic - pharmacology ; Peptomers ; Pharmacology. Drug treatments ; Receptor, Melanocortin, Type 4 - agonists</subject><ispartof>Bioorganic & medicinal chemistry, 2010-01, Vol.18 (2), p.580-589</ispartof><rights>2009 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2009 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-cacd856bd2e4a4fec7c84ba6401e385920a6ac1eeaf60904da74a80c68dbfba93</citedby><cites>FETCH-LOGICAL-c448t-cacd856bd2e4a4fec7c84ba6401e385920a6ac1eeaf60904da74a80c68dbfba93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmc.2009.12.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22367190$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20056544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ovadia, Oded</creatorcontrib><creatorcontrib>Linde, Yaniv</creatorcontrib><creatorcontrib>Haskell-Luevano, Carrie</creatorcontrib><creatorcontrib>Dirain, Marvin L.</creatorcontrib><creatorcontrib>Sheynis, Tanya</creatorcontrib><creatorcontrib>Jelinek, Raz</creatorcontrib><creatorcontrib>Gilon, Chaim</creatorcontrib><creatorcontrib>Hoffman, Amnon</creatorcontrib><title>The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>General structure of peptides, peptoids, peptomers and backbone cyclic peptomers.
A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe-
d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) which participates in regulation of energy homeostasis and appetite. The library of peptomers included a peptoid bond in the Phe and/or
d-Phe position and consisted of linear and backbone cyclic analogs, differed in their ring size. While the linear peptides rapidly degraded in serum and in brush border membrane vesicles (BBMV’s), the linear peptomers were more stable. Backbone cyclic peptomers were also stable under the same conditions. Backbone cyclization significantly increased the intestinal permeability of two peptomers compared to their linear counterparts, in the Caco-2 model. Pharmacological evaluation revealed that two linear and one backbone cyclic peptomer, were found active towards MC4R at the nanomolar range. Thus, the conformational constrains imposed by these local and global modifications affect both the pharmacokinetic and pharmacodynamic properties of the parent peptide. This study demonstrates the potential of imposing backbone cyclization on bioactive peptomers as a promising approach in developing an orally available peptidomimetic drug leads.</description><subject>Backbone cyclization</subject><subject>Biological and medical sciences</subject><subject>Biological Transport - drug effects</subject><subject>Caco-2 Cells</subject><subject>Cell Line</subject><subject>Cell Membrane Permeability - drug effects</subject><subject>Cyclization</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Melanocortin</subject><subject>Molecular Conformation</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptide Library</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Peptides, Cyclic - chemical synthesis</subject><subject>Peptides, Cyclic - chemistry</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Peptomers</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptor, Melanocortin, Type 4 - agonists</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhi0EotvCA3BBviBOSe3E643hVBUKiEr0UM7WZDxpvSRxsLOVlgPPjsMucEOyNJfv_zX-hrEXUpRSSH2-LdsBy0oIU8qqFFI8YiuptCrq2sjHbCWMbgrRGH3CTlPaCiEqZeRTdpIja71WasV-3t4Tp64jnHnoeAv4rQ0jcdxj73_A7MPI87v5fH7zjk8xTBRnT-k36wPg7B-ITzTN3lGxzOAdv9-30bv0hi_lA_UwBgw5N3K4C6NPM58ggvN3wzP2pIM-0fPjPGNfr97fXn4srr98-HR5cV2gUs1cIKBr1rp1FSlQedkNNqoFrYSkulmbSoAGlETQaWGEcrBR0AjUjWu7Fkx9xl4fevMXvu8ozXbwCanPq1HYJbtZjAkldCblgcQYUorU2Sn6AeLeSmEX63Zrs3W7WLeystl6zrw8tu_agdzfxB_NGXh1BCAh9F2EEX36x1W13kizFL09cJRdPHiKNqGnEcn5mC9kXfD_WeMXYhmh-w</recordid><startdate>20100115</startdate><enddate>20100115</enddate><creator>Ovadia, Oded</creator><creator>Linde, Yaniv</creator><creator>Haskell-Luevano, Carrie</creator><creator>Dirain, Marvin L.</creator><creator>Sheynis, Tanya</creator><creator>Jelinek, Raz</creator><creator>Gilon, Chaim</creator><creator>Hoffman, Amnon</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100115</creationdate><title>The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm</title><author>Ovadia, Oded ; Linde, Yaniv ; Haskell-Luevano, Carrie ; Dirain, Marvin L. ; Sheynis, Tanya ; Jelinek, Raz ; Gilon, Chaim ; Hoffman, Amnon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-cacd856bd2e4a4fec7c84ba6401e385920a6ac1eeaf60904da74a80c68dbfba93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Backbone cyclization</topic><topic>Biological and medical sciences</topic><topic>Biological Transport - drug effects</topic><topic>Caco-2 Cells</topic><topic>Cell Line</topic><topic>Cell Membrane Permeability - drug effects</topic><topic>Cyclization</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Melanocortin</topic><topic>Molecular Conformation</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptide Library</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Peptides, Cyclic - chemical synthesis</topic><topic>Peptides, Cyclic - chemistry</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Peptomers</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptor, Melanocortin, Type 4 - agonists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ovadia, Oded</creatorcontrib><creatorcontrib>Linde, Yaniv</creatorcontrib><creatorcontrib>Haskell-Luevano, Carrie</creatorcontrib><creatorcontrib>Dirain, Marvin L.</creatorcontrib><creatorcontrib>Sheynis, Tanya</creatorcontrib><creatorcontrib>Jelinek, Raz</creatorcontrib><creatorcontrib>Gilon, Chaim</creatorcontrib><creatorcontrib>Hoffman, Amnon</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ovadia, Oded</au><au>Linde, Yaniv</au><au>Haskell-Luevano, Carrie</au><au>Dirain, Marvin L.</au><au>Sheynis, Tanya</au><au>Jelinek, Raz</au><au>Gilon, Chaim</au><au>Hoffman, Amnon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2010-01-15</date><risdate>2010</risdate><volume>18</volume><issue>2</issue><spage>580</spage><epage>589</epage><pages>580-589</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>General structure of peptides, peptoids, peptomers and backbone cyclic peptomers.
A peptide–peptoid hybrid (peptomer) library was designed and synthesized, based on the sequence Phe-
d-Phe-Arg-Trp-Gly. This sequence was previously found to specifically activate the melanocortin-4-receptor (MC4R) which participates in regulation of energy homeostasis and appetite. The library of peptomers included a peptoid bond in the Phe and/or
d-Phe position and consisted of linear and backbone cyclic analogs, differed in their ring size. While the linear peptides rapidly degraded in serum and in brush border membrane vesicles (BBMV’s), the linear peptomers were more stable. Backbone cyclic peptomers were also stable under the same conditions. Backbone cyclization significantly increased the intestinal permeability of two peptomers compared to their linear counterparts, in the Caco-2 model. Pharmacological evaluation revealed that two linear and one backbone cyclic peptomer, were found active towards MC4R at the nanomolar range. Thus, the conformational constrains imposed by these local and global modifications affect both the pharmacokinetic and pharmacodynamic properties of the parent peptide. This study demonstrates the potential of imposing backbone cyclization on bioactive peptomers as a promising approach in developing an orally available peptidomimetic drug leads.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20056544</pmid><doi>10.1016/j.bmc.2009.12.010</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0968-0896 |
ispartof | Bioorganic & medicinal chemistry, 2010-01, Vol.18 (2), p.580-589 |
issn | 0968-0896 1464-3391 |
language | eng |
recordid | cdi_proquest_miscellaneous_733910406 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Backbone cyclization Biological and medical sciences Biological Transport - drug effects Caco-2 Cells Cell Line Cell Membrane Permeability - drug effects Cyclization Humans Medical sciences Melanocortin Molecular Conformation Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Peptide Library Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems Peptides, Cyclic - chemical synthesis Peptides, Cyclic - chemistry Peptides, Cyclic - pharmacology Peptomers Pharmacology. Drug treatments Receptor, Melanocortin, Type 4 - agonists |
title | The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: The melanocortin agonist paradigm |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T00%3A51%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20backbone%20cyclization%20on%20PK/PD%20properties%20of%20bioactive%20peptide-peptoid%20hybrids:%20The%20melanocortin%20agonist%20paradigm&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Ovadia,%20Oded&rft.date=2010-01-15&rft.volume=18&rft.issue=2&rft.spage=580&rft.epage=589&rft.pages=580-589&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2009.12.010&rft_dat=%3Cproquest_cross%3E733910406%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733910406&rft_id=info:pmid/20056544&rft_els_id=S0968089609010943&rfr_iscdi=true |